This implant can restore sight for patients with macular degeneration

Age-related macular degeneration (AMD) affects more than 5 million people around the world. And until now, no treatment could restore their vision. The Prima system, which was approved in Europe in July and is awaiting FDA clearance in the US, changes that. It combines a retinal implant with camera…
Résumé
What is AMD?
Age-related macular degeneration, or AMD, is a common eye condition that affects more than 5 million people worldwide.
It primarily impacts the macula, the central part of the retina responsible for sharp, detailed vision.
In advanced stages, AMD causes a blind spot in the middle of a person’s vision, making activities like reading, recognizing faces, or using a phone difficult.
The condition does not lead to complete blindness but significantly reduces the ability to see fine details.
AMD develops as people age, and its exact cause remains unclear, though factors like genetics and lifestyle may play a role.
Until recently, no treatment could restore vision lost to AMD, leaving many patients with limited options for managing their condition.
Lire l'analyse complète en 6 points →
Commentaires (0)
Connecte-toi pour commenter
Se connecterAucun commentaire pour le moment.
Voir aussi
Plus de contenus dans cette catégorie →Découvre plus de contenu sur Napseflow


